2 hot growth stocks I would consider buying right now

These two shares could offer a powerful mix of growth and value potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Beating the stock market is never easy. However, with the FTSE 100 trading at a new all-time high, finding stocks which offer above-average growth at reasonable prices is becoming more challenging. Despite this, growth stocks which appear to be undervalued are still in existence for investors who are willing to scour the markets looking for them. Here are two prime examples which could deliver index-beating returns in 2017 and beyond.

Improving performance

Reporting on Monday was high-performance polymer solutions specialist Victrex (LSE: VCT). It announced a rise in group revenue of 12% for the first six months of its financial year, with volume growth contributing 5% towards sales growth. With no change to the company’s gross margin, this means gross profit was also 12% higher when compared to the same period of the prior year. This allowed the company to raise dividends per share by 4%, which puts it on a dividend yield of around 2.3%.

In terms of the breakdown of its performance, Victrex endured a somewhat mixed period. Its core business enjoyed strong growth and this helped to offset lower year-on-year volumes in Consumer Electronics. Similarly, the performance in the company’s Medical division remains muted, which reflects the maturity of the US Spine market. However, with a strong product pipeline and scope for growth within the differentiated products space, its outlook remains upbeat.

In fact, Victrex is forecast to record a rise in its bottom line of 7% in the current year, followed by further growth of 10% next year. This puts it on a price-to-earnings growth (PEG) ratio of only 1.6, which suggests that it offers growth at a reasonable price. Therefore, now could be the perfect time to buy it.

Low valuation

Also offering the scope for FTSE 100-beating performance is plastic components supplier Carclo (LSE: CAR). It has a strong track record of growth, with its bottom line having risen at a double-digit pace in each of the last three years. In fact, its earnings have grown at an annualised rate of 25% during the period. This has helped to push the company’s share price almost 30% higher during the last three years.

Despite this high rate of growth, Carclo continues to offer excellent value for money. For example, it trades on a price-to-earnings (P/E) ratio of 13, which suggests further share price growth could be ahead. Making this more likely is a high forecast rate of earnings growth over the next two years. Carclo is expected to record a rise in its bottom line of 13% this year, followed by further growth of 21% next year.

This puts its shares on a forward P/E ratio of just 9.6, which suggests they could rise significantly and remain modestly valued. Therefore, they could continue to outperform the wider index, as they have done by 22% in the last three years.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has recommended Victrex. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »